🔵 ADVANCE YOUR RESEARCH WITH TIRZEPATIDE 30MG

Premium Research Compound by Regenix Peptides

Discover the future of metabolic and endocrine research with Tirzepatide 30mg from Regenix Peptides.

Manufactured to rigorous quality standards, this high-purity lyophilized peptide is designed to support advanced laboratory investigations and preclinical research applications.

Tirzepatide is an investigational dual receptor agonist currently being studied for its interaction with both GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor pathways, making it an important compound in modern metabolic research.

Researchers utilize Tirzepatide in studies involving:

🧬 Metabolic Regulation Research
⚡ Energy Balance & Expenditure Studies
🩸 Glucose Homeostasis Research
🔬 Endocrine Pathway Investigations
🧪 Obesity & Metabolic Research Models
🧠 Advanced Preclinical Scientific Studies

📋 PRODUCT SPECIFICATIONS

🧪 ABOUT TIRZEPATIDE

Tirzepatide is a novel dual GIP and GLP-1 receptor agonist currently being investigated for its potential role in metabolic regulation and endocrine research. Due to its unique mechanism of action involving multiple metabolic pathways, Tirzepatide has become a compound of significant scientific interest in preclinical research.

🔹 Dual GIP & GLP-1 Receptor Agonist
🔹 Widely Studied for Metabolic Research
🔹 Supports Advanced Scientific Investigations
🔹 Ideal for Preclinical & Laboratory Studies
🔹 Manufactured to Strict Quality Standards
🔹 Third-Party Tested for Purity & Identity

⚠️ RESEARCH USE DISCLAIMER

FOR LABORATORY RESEARCH PURPOSES ONLY

This product is intended strictly for research and laboratory use only and is not for human consumption, therapeutic use, or diagnostic applications.